20-F: UMeWorld Limited Reports Increased Revenue but Continues to Face Going Concern Challenges in 2023 20-F Filing

Sentiment:

Annual Results


UMeWorld Limited's 20-F filing reveals increased revenue driven by DAG Oil sales, but the company still faces significant financial challenges and doubts about its ability to continue as a going concern.

Capital raiseThe company states that it will need to raise additional capital to fund its operations in the future.The company intends to finance its future working capital requirements and capital expenditures from cash generated from operating activities and funds raised from financing activities.The company may seek to sell equity, sell debt securities or borrow from banks if existing cash resources are insufficient.
Worse than expectedThe company's net loss increased compared to the previous year.The company's auditor expressed substantial doubt about its ability to continue as a going concern.The company identified material weaknesses in its internal control over financial reporting.

Summary

  • UMeWorld Limited's 20-F filing covers the fiscal year ended September 30, 2023.
  • The company is a holding company with operations conducted through its subsidiary, Dagola Inc., in the United States.
  • Prior to January 2022, UMeWorld conducted operations through a VIE in China, which was terminated in December 2021.
  • The company is transitioning into a health and wellness company, focusing on DAG (Diacylglycerol) cooking oils and nutritional supplements.
  • Revenue increased from $93 in 2022 to $1,401 in 2023, driven by sales of DAG Oil and a calcium product.
  • The company incurred a net loss of $306,340 for the year ended September 30, 2023, compared to a net loss of $147,686 in the previous year.
  • As of September 30, 2023, the company had an accumulated deficit of $31,447,003.
  • The auditor's report expresses substantial doubt about the company's ability to continue as a going concern.
  • The company is pursuing acquisitions in the edible oils industry, expecting to complete a joint venture agreement in 2024.
  • The company identified material weaknesses in its internal control over financial reporting.

Sentiment

Score: 3

Explanation: The document presents a mixed picture. While revenue increased, the company is still operating at a loss and faces significant financial challenges, including doubts about its ability to continue as a going concern and material weaknesses in internal controls. The sentiment is therefore negative.

Positives

  • Revenue increased significantly due to sales of DAG Oil and a calcium product.
  • The company is transitioning into the health and wellness market, which has a large potential.
  • The company is actively pursuing acquisitions to expand its business in the edible oils industry.
  • DAG oil has potential health benefits and is approved by the FDA as GRAS.
  • The company is working to remediate material weaknesses in internal control over financial reporting.

Negatives

  • The company incurred a net loss of $306,340 for the year ended September 30, 2023.
  • The company has a significant accumulated deficit of $31,447,003.
  • Auditors expressed substantial doubt about the company's ability to continue as a going concern.
  • The company has identified material weaknesses in its internal control over financial reporting.
  • The company has limited cash resources and a history of operating losses.

Risks

  • The company's ability to continue as a going concern is uncertain.
  • The company may fail to successfully execute its business plan.
  • The company's acquisition strategy creates risks, including integration challenges and potential overvaluation of acquired companies.
  • The company may be unable to scale its operations successfully.
  • The company may be unable to retain key employees or recruit additional qualified personnel.
  • The company's products may not meet health and safety standards or could become contaminated.
  • The company may lose its foreign private issuer status, resulting in additional costs and expenses.
  • The market price of the company's ordinary shares is volatile.
  • The company's ordinary shares are classified as penny stock, making it more difficult for shareholders to resell their shares.
  • The company has identified material weaknesses in its internal control over financial reporting.

Future Outlook

The company intends to finance future working capital requirements and capital expenditures from cash generated from operating activities and funds raised from financing activities and is pursuing acquisitions in the edible oils industry, expecting to complete a joint venture agreement in 2024.

Management Comments

  • The management team brings deep expertise in heavily regulated industries, operating, brand identity and services, and raising capital to the public market.
  • We seek synergistic and complementary mergers and acquisition opportunities, implementing operational efficiencies to eliminate duplicative measures and centralize administrative operations to achieve more significant revenues and profitability.
  • Additionally, we expect to leverage our network of retail relationships, as well as acquire and manage brands and services cultivated in the health and wellness industry to secure sales in major retailers in the United States and globally.

Industry Context

The company is transitioning into the health and wellness market, which is a $1.5 trillion global industry. The company also competes in the edible oils industry, which is highly competitive with many well-known brands.

Comparison to Industry Standards

  • The document does not provide enough information to make a detailed comparison to industry standards.
  • Without specific financial benchmarks for comparable companies in the health and wellness or edible oils industries, a thorough assessment is not possible.
  • Companies like Unilever, Nestle, and Bunge are major players in the edible oils market, and their financial performance could be used as a benchmark if more specific details were available about UMeWorld's operations and target market.

Related Party Transactions

  • Michael Lee provided management services to the Company with the amount of $80,000 during the year ended September 30, 2023.
  • The company issued 300,000 restricted shares to Winfield, Yongbiao Ding, the CFO of the Company, at $0.10 per share on November 22, 2019.
  • The company issued 1,000,000 restricted shares to Ford Moore, a director of the Company at $0.05 per share on April 13, 2020.
  • The company issued a total of 1,078,445 restricted shares to Ruby Hui, over 5% shareholder of the Company at $0.05 per share on August 27, 2020 and September 16, 2020.
  • The company issued a total of 800,000 restricted shares to Ruby Hui, over 5% shareholder of the Company at $0.05 per share on October 28, 2020.
  • The company issued 100,000 shares at a price of $0.12 per share to Winfield, Yongbiao Ding, the CFO of the Company on February 23, 2021.

Stakeholder Impact

  • Shareholders face the risk of losing their investment if the company fails to execute its business plan or is unable to continue as a going concern.
  • Employees may be affected by potential cost-cutting measures or restructuring if the company's financial situation does not improve.
  • Customers may benefit from the company's focus on health and wellness products, but the company's financial instability could impact its ability to deliver consistent quality and service.
  • Suppliers and creditors face the risk of non-payment if the company's financial situation deteriorates.

Next Steps

  • The company plans to pursue acquisitions in the edible oils industry.
  • The company expects to complete a joint venture agreement in 2024.
  • The company will prepare written policies and procedures for accounting and financial reporting.
  • The company plans to hire additional accounting and finance staff and invest in technology infrastructure.

Key Dates

DateDescription
1997-08-08AlphaRx Inc. incorporated in Delaware
2011-11-04Company ceased drug development operations and shifted to digital media and education
2012-02-23UMeLook Limited incorporated in Hong Kong
2013-01-07Company re-domiciled to British Virgin Islands
2013-03-08AlphaRx changed its name to UMeWorld Limited
2021-12-31VIE contractual arrangements terminated, dissolving the education business in China
2022-01-28Dagola Inc. incorporated in Wyoming
2022-09-30Company entered into agreements to dispose of UMeLook HK and UMeZone
2023-09-30End of fiscal year
2024Expected completion of joint venture agreement in the edible oils industry
2024-01-31Date of 20-F filing

Keywords

UMeWorld, DAG Oil, Edible Oils, Health and Wellness, Financial Results, Going Concern, Acquisition, Internal Control, 20-F Filing, Revenue

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.